![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C12Q 1/68 | |
C12N 9/12 | |||
G01N 33/574 |
(11) | Number of the document | 2580322 |
(13) | Kind of document | T |
(96) | European patent application number | 11735711.1 |
Date of filing the European patent application | 2011-06-09 | |
(97) | Date of publication of the European application | 2013-04-17 |
(45) | Date of publication and mention of the grant of the patent | 2018-01-10 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2011/039789 |
Date | 2011-06-09 |
(87) | Number | WO 2011/156588 |
Date | 2011-12-15 |
(30) | Number | Date | Country code |
352959 P | 2010-06-09 | US |
(72) |
GARRAWAY, Levi, A., US
EMERY, Caroline, US
WAGLE, Nikhil, US
|
(73) |
Dana-Farber Cancer Institute, Inc.,
450 Brookline Avenue, Boston, MA 02215,
US
|
(54) | A MEK 1 MUTATION CONFERRING RESISTANCE TO RAF AND MEK INHIBITORS |
A MEK 1 MUTATION CONFERRING RESISTANCE TO RAF AND MEK INHIBITORS |